FCF YoY
+12.14%
OCF YoY
+14.34%
Capex YoY
+53.22%
FCF Conversion Δ
-1.8 pp
Free cash flow bridge for ResMed (RMD) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Free cash flow: $189.88M
FCF bridge breakdown for ResMed (RMD) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Free Cash Flow | $1.56B | — |
| Operating Cash Flow | $237.03M | +124.8% |
| Capital Expenditure | −$47.15M | -24.8% |
| Free Cash Flow | $1.75B | — |
- Prior Free Cash Flow$1.56B
- Operating Cash Flow$237.03M
- Capital Expenditure−$47.15M
- Free Cash Flow$1.75B
Identity check: drivers reconcile to ΔNI within $0.00 ✓
Want to see how cash flow is built up?Cash Flow Waterfall
Frequently asked questions
Data & methodology
ResMed (RMD) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement